*Developments: Roche (Archives 2010-2014)

Parents

2010: Roche and reMYND's DDD enter into a strategic alliance to develop first-in-class disease-modifying treatments for Parkinson's and Alzheimer's disease (2010)
2011: PTC Therapeutics licensing agreement with Roche valued up to $490 million (2011)
2012: Med Fusion in 2012 landed a 5-year contract naming it a Roche Molecular Center of Excellence.
2012: Roche Signs $646 Million Pain Pact With Xenon (2012)
2013 Medical Device Manufacturer of the Year Finalists: Roche Diagnostics
2013: PacBio soars in wake of $75M Dx deal with Roche
2013: Roche heralds its return to the antibiotics field with $560M Polyphor deal (2013)
2014: NewLink in $1 billion deal with Roche to develop cancer drug
2014: Roche Back in Sequencing Game with $350M Genia Acquisition
2014: Roche More Than Optimistic On Its Diagnostic
2014: Roche, Quintiles partner for companion diagnostics in China